Page last updated: 2024-09-03
neo-kyotorphin and h 89
neo-kyotorphin has been researched along with h 89 in 1 studies
Compound Research Comparison
| Studies (neo-kyotorphin) | Trials (neo-kyotorphin) | Recent Studies (post-2010) (neo-kyotorphin) | Studies (h 89) | Trials (h 89) | Recent Studies (post-2010) (h 89) |
|---|---|---|---|---|---|
| 41 | 0 | 0 | 1,619 | 0 | 409 |
Protein Interaction Comparison
| Protein | Taxonomy | neo-kyotorphin (IC50) | h 89 (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 1.9504 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.12 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.073 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | 0.381 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | 0.6365 | |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.08 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 1.9886 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5417 | |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | 0.27 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3207 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Blishchenko, EY; Ivanov, VT; Karelin, AA; Khachin, DP; Leontiev, KV; Sazonova, OV; Tolmazova, AG | 1 |
Other Studies
1 other study(ies) available for neo-kyotorphin and h 89
| Article | Year |
|---|---|
Stimulation of fibroblast proliferation by neokyotorphin requires Ca influx and activation of PKA, CaMK II and MAPK/ERK.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anticonvulsants; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Proliferation; Chelating Agents; Chlorocebus aethiops; Endorphins; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Isoquinolines; MAP Kinase Signaling System; Mice; Nifedipine; Protein Kinase Inhibitors; Sulfonamides; Verapamil | 2007 |